Warburg Pincus nears deal to buy PANTHERx Rare for over $7 billion

The specialty-pharmacy company is owned by an investor consortium that includes private-equity firm General Atlantic, according to people familiar with the matter.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.